Preferred Label : osteoporosis, postmenopausal;

MeSH definition : Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.;

MeSH synonym : osteoporosis, post-menopausal; postmenopausal bone losses; postmenopausal osteoporoses; perimenopausal bone losses; postmenopausal bone loss; post-menopausal osteoporosis; bone loss, postmenopausal; perimenopausal bone loss; bone losses, postmenopausal; osteoporoses, post-menopausal; osteoporosis, post menopausal; post-menopausal osteoporoses; postmenopausal osteoporosis; osteoporoses, postmenopausal; bone loss, perimenopausal; bone losses, perimenopausal;

MeSH annotation : in females; don't forget also check tags HUMANS FEMALE; corresponding age-related osteoporosis in men goes under OSTEOPOROSIS;

Details


Main resources

You can consult :

Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

https://www.cochrane.org/fr/CD001155/CENTRALED_lalendronate-previent-il-les-fractures-causees-par-losteoporose-chez-les-femmes-post-menopausees
2025
false
United Kingdom
France
French
meta-analysis
osteoporosis, postmenopausal
osteoporotic fractures
alendronate
treatment outcome
bone density conservation agents
french abstract

---
http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
http://www.grio.org/documents/page/evalios-grio-rev-rhum-2020.pdf
2020
false
false
false
France
guideline adherence
practice guidelines as topic
osteoporotic fractures
rheumatology
general practice
bone density conservation agents
journal article
patient care management
osteoporosis, postmenopausal

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1250
2019
false
false
false
false
Canada
critical appraisal or critical reading
bone density conservation agents
osteoporosis, postmenopausal
alendronate
bone density conservation agents
spinal fractures
spinal fractures
journal article
alendronate
osteoporotic fractures
female
romosozumab
antibodies, monoclonal
romosozumab
antibodies, monoclonal

---
http://www.grio.org/documents/page240/recosoppm2018-revrhum.pdf
2018
false
false
true
France
French
practice guideline
osteoporosis, postmenopausal
risk assessment
osteoporotic fractures
osteoporosis, postmenopausal
accidental falls
watchful waiting

---
https://www.pharmactuel.com/index.php/pharmactuel/article/view/1198
2018
false
false
false
Canada
French
SOST protein, human
osteoporotic fractures
hip fractures
spinal fractures
treatment outcome
critical appraisal or critical reading
romosozumab
osteoporosis, postmenopausal
romosozumab
antibodies, monoclonal
romosozumab
genetic markers
bone morphogenetic proteins
antibodies, monoclonal

---
https://www.revmed.ch/RMS/2017/RMS-N-559/Denosumab-en-routine-clinique-precautions-a-prendre-avant-pendant-et-apres
2018
false
false
false
Switzerland
French
journal article
continuity of patient care
treatment outcome
Denosumab
denosumab
injections, subcutaneous
Denosumab
osteoporosis
rank ligand
renal insufficiency
calcium
osteoporosis, postmenopausal
Calcium supplement therapy (regime/therapy)
calcium
Vitamin D supplement therapy (regime/therapy)
case reports
spinal fractures
Therapy cessation
hypocalcemia
vitamin d deficiency
bone density conservation agents
bone density conservation agents
Rebound effect
diphosphonates
fractures, spontaneous
bone neoplasms
bone neoplasms
Routine health maintenance
Tumor Necrosis Factor Inhibitors

---
https://ecm.univ-rennes1.fr/nuxeo/site/esupversions/393fc341-0943-4d62-a41f-94da6c27325c
2017
false
false
false
France
French
dissertations, academic
general practice
professional practice
general practitioners
osteoporosis, postmenopausal

---
http://www.grio.org/documents/page240/recommandations-opm-grio-2016-2017.pdf
2017
false
false
false
France
French
guideline
therapeutics
osteoporosis
osteoporosis, nos
directive counseling
recommendations, health planning
treaties
osteoporosis, postmenopausal
osteoporosis
health planning guidelines
international cooperation
osteoporosis

---
Medikamentöse Osteoporose-therapie: Behandlungsdauer und Vorgehen nach Therapieende
https://smf.swisshealthweb.ch/fr/article/doi/fms.2017.03062/
10.4414/fms.2017.03062
2017
false
false
false
Switzerland
French
German
journal article
osteoporosis, postmenopausal
diphosphonates
bisphosphonates
Denosumab
practice guidelines as topic
denosumab
bone density conservation agents
rank ligand
comparative effectiveness research
teriparatide
teriparatide
Duration of treatment (qualifier value)
osteoporotic fractures
treatment outcome
spinal fractures
guidelines for drug use
bone density
risk
vitamin D
hip fractures
Rebound effect
Therapy cessation
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-07/reeval_thm_rapport_devaluation_annexe.pdf
2014
false
true
false
false
France
French
drug evaluation
estrogen replacement therapy
menopause
osteoporosis, postmenopausal
postmenopause
risk assessment
osteoporotic fractures
treatment outcome
estrogen replacement therapy
estrogen deficiency

---
http://www.grio.org/documents/page240/avis-du-grio-240-1448658656.pdf
2014
false
false
false
France
French
journal article
absorptiometry, photon
accidental falls
risk assessment
osteoporotic fractures
osteoporosis, postmenopausal

---
https://www.jogc.com/article/S1701-2163(15)30490-4/abstract
10.1016/S1701-2163(15)30490-4
2014
false
true
false
false
Canada
French
osteoporosis, postmenopausal
practice guideline
osteoporosis, postmenopausal

---
http://www.grio.org/documents/page246/rcd-9-1352803804.pdf
2012
false
France
French
practice guideline
osteoporosis, postmenopausal
osteoporosis, postmenopausal

---
https://www.boitedecision.ulaval.ca/fileadmin/documents/Boites_PDF/Bisphosphonates/DBox_bisphosphonates_FR.pdf
2012
false
false
false
false
Canada
French
decision making
popular works
osteoporosis, postmenopausal
fractures, bone
diphosphonates
scientific and technical information

---
https://www.amub-ulb.be/system/files/rmb/old/461
2008
journal article
osteoporosis
osteoporosis, postmenopausal

---
http://www.cochrane.org/fr/CD005326
2008
false
true
false
United Kingdom
France
osteoporosis, postmenopausal
treatment outcome
review of literature
french abstract
osteoporosis, postmenopausal
strontium ranelate
strontium

---
https://www.has-sante.fr/jcms/r_1439939
2008
true
France
French
diphosphonates
imidazoles
bone density conservation agents
osteoporosis, postmenopausal
injections, intravenous
zoledronic acid
guidelines for drug use
Zoledronic Acid
Zoledronic Acid

---
https://minerva-ebp.be/fr/article/588
2007
false
minerva-ebm.be
Belgium
French
osteoporosis, postmenopausal
imidazoles
diphosphonates
imidazoles
diphosphonates
fractures, bone
drug evaluation
diphosphonates
imidazoles
critical appraisal or critical reading
Zoledronic Acid

---
https://rmlg.uliege.be/article/1596
2007
Belgium
French
osteoporosis, postmenopausal
diphosphonates
bone density conservation agents
selective estrogen receptor modulators
journal article

---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F07B
2007
Belgium
French
osteoporosis, postmenopausal
osteoporosis, postmenopausal
journal article

---
https://www.jle.com/fr/revues/medecine/med/e-docs/00/04/25/1F/resume.md?type=text.html
2006
France
French
osteoporosis, postmenopausal
fractures, bone
risk factors
osteoporosis, postmenopausal
journal article

---
https://rmlg.uliege.be/article/1495
2006
Belgium
French
drug administration schedule
bone density conservation agents
diphosphonates
bone density conservation agents
osteoporosis, postmenopausal
medication adherence
diphosphonates
journal article
Ibandronic Acid

---
http://www.has-sante.fr/portail/display.jsp?id=c_437000
2006
true
France
French
absorptiometry, photon
osteoporosis
osteoporosis
osteoporosis
osteoporosis
age factors
bone development
risk factors
osteoporosis
bone density
osteoporosis, postmenopausal
menopause
insurance, health, reimbursement
handbooks
practice guideline
osteoporosis, postmenopausal

---
https://minerva-ebp.be/FR/Article/783
2005
false
false
minerva-ebm.be
Belgium
French
Evidence-Based medicine
osteoporosis, postmenopausal
fractures, bone
absorptiometry, photon
risk factors
mass screening
osteoporosis, postmenopausal
critical appraisal or critical reading

---
https://www.cadth.ca/sites/default/files/pdf/117_raloxifene_tr_f.pdf
https://www.cadth.ca/fr/etude-methodique-de-lefficacite-et-de-linnocuite-du-raloxifene-dans-la-prevention-primaire-ou
2005
true
Canada
French
Raloxifene Hydrochloride
osteoporosis, postmenopausal
selective estrogen receptor modulators
fractures, bone
Raloxifene Hydrochloride
selective estrogen receptor modulators
treatment outcome
randomized controlled trials as topic
aged
canada
osteoporosis, postmenopausal
spinal fractures
bone density
osteoporosis, postmenopausal
signs and symptoms
risk factors
bibliography of medicine
incidence
placebos
fractures, bone
prevalence
thromboembolism
hot flashes
breast neoplasms
cardiovascular diseases
morbidity
bone density conservation agents
technical report
evaluation studies
french abstract
meta-analysis

---
https://rmlg.uliege.be/article/1138
2004
Belgium
French
osteoporosis, postmenopausal
journal article

---
https://minerva-ebp.be/fr/article/807
2004
false
false
minerva-ebm.be
Belgium
French
alendronate
osteoporosis, postmenopausal
treatment outcome
fractures, bone
bone density
critical appraisal or critical reading

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/met/e-docs/00/04/0A/6A/resume.md
http://www.john-libbey-eurotext.fr/fr/revues/medecine/met/e-docs/00/04/0A/6A/article.md?type=text.html
2004
France
French
osteoporosis, postmenopausal
osteoporosis, postmenopausal
signs and symptoms
bone density
fractures, spontaneous
diphosphonates
risk factors
osteoporosis, postmenopausal
Raloxifene Hydrochloride
selective estrogen receptor modulators
hormone replacement therapy
calcium
vitamin D
teriparatide
continuity of patient care
drug therapy
aged
densitometry
journal article

---
http://www.cmaj.ca/cgi/reprint/168/6_suppl/SF1.pdf
2003
Canada
French
canada
osteoporosis
osteoporosis
risk factors
population characteristics
aged
osteoporosis, postmenopausal
bone density
risk assessment
age factors
fractures, spontaneous
age distribution
sex distribution
accidental falls
osteoporosis
osteoporosis, postmenopausal
prednisone
osteoporosis
osteoporosis, postmenopausal
fractures, bone
densitometry
densitometry
predictive value of tests
continuity of patient care
spinal fractures
bone remodeling
Biomarkers
osteoporosis
osteoporosis
osteoporosis, postmenopausal
osteoporosis, postmenopausal
spinal fractures
diphosphonates
diphosphonates
calcitonin
calcitonin
calcitonin
administration, intranasal
hormone replacement therapy
menopause
premenopause
hormone replacement therapy
Raloxifene Hydrochloride
Raloxifene Hydrochloride
estrogen antagonists
estrogen antagonists
complementary therapies
vitamin K
isoflavones
fluorine
fluorine
diet
parathyroid hormone
exercise
child
algorithms
fractures, spontaneous
fractures, spontaneous
adult
middle aged
absorptiometry, photon
absorptiometry, photon
Evidence-Based medicine
practice guideline
journal article
osteoporosis
spinal fractures
fractures, bone
osteoporosis, postmenopausal

---
http://www.ulb.ac.be/esp/gras/x11.htm
2002
Belgium
French
guidelines
treatment outcome
diphosphonates
calcium
osteoporosis, postmenopausal
estrogens
drug evaluation
osteoporosis, postmenopausal
Raloxifene Hydrochloride
alendronate
calcitonin
Evidence-Based medicine

---
http://www.has-sante.fr/portail/display.jsp?id=c_271924
2001
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
osteoporosis, postmenopausal
osteoporosis
glucocorticoids
osteoporosis
osteoporosis
osteoporosis
signs and symptoms
fractures, spontaneous
densitometry
bone density
practice guideline

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.